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Abstract: We present herein a promising novel strategy for the
transformation of sugar aldehydes into 1,2-diaminoinositols. This
process, based on the sequential intermolecular aza-Henry reaction
and intermolecular Henry reaction allowed the total synthesis of a
1,2-diaminoinositols with total stereochemical control. The new
route constitutes a simpler and more efficient approach than those
previously described routes to 1,2-diaminoinositols and it has the
additional advantage of offering the possibility of orthogonal pro-
tection of the amino groups.
Key words: Henry reaction, aza-Henry reaction, bromonitro-
alkanes, 1,2-diaminoinositols, 2-nitroamines
Aminocyclitols are members of a large family of natural
products with interesting biological properties1 and great
importance as synthetic intermediates in natural product
chemistry.2 In particular, the aminocyclitol moiety is a
component of a variety of potent antibiotics, glycosidase
inhibitors, and other relevant biologically active com-
pounds. 1,2-Diaminoinositols are a group of aminocycli-
tols whose structure consists of a cyclohexane ring
containing two vicinal amino groups and at least three ad-
ditional hydroxyl groups on the ring atoms. The interest in
these compounds has grown rapidly, as they are rigid scaf-
folds, extremely valuable for the design of chiral catalysts
or ligands for asymmetric catalysis and metal complexes
of value in medicinal chemistry. Thus, the 1,2-diaminoi-
nositol framework has been incorporated into new salen
asymmetric catalysts3 and also into new water-soluble an-
titumor platinum complexes4 and other chelating agents.5
Moreover, it was recently reported that amides derived
from the simple trans-1,2-cyclohexanediamines are ‘uni-
versal’ gelling agents.6 Despite all this recent interest,
there is only a handful of stereoselective synthetic proto-
cols leading to orthogonally protected 1,2-diaminoinosi-
tols, and most of the described procedures afford
identically N,N′-disubstituted compounds.7
In connection with our recent research into the synthesis
of carbohydrate-based stereodifferentiation agents,8 we
were interested in the development of a versatile synthetic
approach for the stereoselective synthesis of orthogonally
protected 1,2-diaminoinositols as scaffolds for the con-
struction of novel organocatalysts. Our route towards tar-
get inositols involves chemical manipulation of a suitably
protected β-nitroamine, derived from sugar aldehydes by
means of a simple and efficient protocol recently de-
scribed in our group.9
Reaction of D-mannose-derived aldehyde 1,10 with bro-
monitromethane in the presence of 4-methoxybenzenam-
ine, titanium(IV) ethoxide, and tin(II) chloride in THF
afforded a mixture of epimeric (5R/5S)-β-nitroamines 2 in
5:1 dr and 72% yield.9a Deprotection of the anomeric po-
sition on treatment with TBAF in THF solution, followed
by in situ intramolecular Henry reaction of the resulting
nitrosugar 3 gave enantiopure nitroinositol 5 as the only
isomer detected in the 1H NMR spectrum of the crude re-
action mixture (Scheme 1).11
Scheme 1  Synthesis of nitroinositol 5 from sugar aldehyde 1
The stereochemistry of compound 5 was firmly estab-
lished using single-crystal X-ray diffraction,12 with the
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0.0(3).13 At 100 K the nitroinositol 5 crystallizes in the
noncentrosymmetric and chiral P1 space group, with the
asymmetric unit being composed by two independent mo-
lecular units as depicted in Figure 1 (a). Both molecules
exhibit, nevertheless, the same stereochemistry for the six-
membered ring: S,R,S,R,R,R for C-1,C-2,C-3,C-4,C-5,C-6,
and C-17,C-18,C-19,C-20,C-21,C-22 [see Figure 1 (a)]. It
is worth noting that this ring exhibits the favored chair
conformation, with an equatorial disposition of the C-3,C-
4 and C-19,C-20 hydrogen atoms, and an axial disposition
for the remaining ones. We further note that this confor-
mation is also the one favored in solution, a fact readily
established from examination of the 1H NMR spectrum of
5, which includes a double doublet at δ = 4.73 ppm due to
the highly deshielded H-1. The coupling constants (J1,2 =
10.5 Hz and J1,6 = 10.5 Hz) indicate an axial disposition
for proton H-1 as well as for adjacent protons H-6 and H-
2. On the other hand, the coupling constants for the dou-
blet at δ = 4.11 ppm (J1,6 = 10.5 Hz and J5,6 = 3.0 Hz), cor-
responding to proton H-6, allowed us to confirm the axial
disposition of this proton and the equatorial disposition of
the proton H-5.
In the solid state, each individual molecular unit of nitroi-
nositol 5 is engaged in a range of supramolecular contacts,
mostly arising from strong and highly directional hydro-
gen-bonding interactions [see the Supporting Information
(SI)]. Considering solely the N–H···O, O–H···O and O–
H···N interactions (see Table S1), the two crystallograph-
ically independent molecular units describe a two-dimen-
sional supramolecular layer placed in the bc plane of the
unit cell (Figure S1a). Individual layers close pack in the
[001] direction to form the crystal structure of 5 (Figure
S1b). Weaker supramolecular interactions are also present
in the crystal structure, namely various weak C–H···O hy-
drogen bonds (Table S1 and Figure S2) and C–H···π con-
tacts (Table S1 and Figure S3). It is noteworthy that each
individual molecular unit is engaged in a different set of
these supramolecular interactions as depicted in Figures
S2 and S3. This structural feature helps to understand the
reason for the presence of these two conformational iso-
mers composing the asymmetric unit of 5.
The fact that reaction of the isomeric mixture 2 afforded
enantiopure nitroinositol 5 as single isomer may be at-
tributed to the reversibility of Henry and aza-Henry reac-
tions,14 allowing isomeric equilibration through open-
chain derivatives.15 Consequently; whereas carbanion 4a,
the reaction intermediate derived from nitrosugar 5R, pro-
ceeds easily to nitroinositol 5, its epimer 4b (the interme-
diate derived from nitrosugar 5S) gives initially
nitroinositol 6, which isomerizes to the more thermo-
dynamically stable nitroinositol 5 through compound 7
via a retro-aza-Henry–aza-Henry sequence (Scheme 2).
Scheme 2  Mechanistic proposal for the formation of nitroinositol 5
The free hydroxyl groups of nitroinositol 5 were protected
by treatment with tris(triethyl)silyl chloride and imidazole
Figure 1  (a) Molecular units composing the asymmetric unit of the
crystal structure of the nitroinositol 5, emphasizing the configuration
for each chiral carbon atom. Nonhydrogen atoms are represented as
thermal ellipsoids drawn at the 60% probability level and hydrogen at-
oms as small spheres with arbitrary radii. Note: The atomic labelling
herein only concerns the crystallographic description of the molecules
and it is not related to that described in the main text. (b) Overlay of
the two crystallographically independent molecular units showing that
the differences between the molecules are essentially due to rotations
of the functional groups: maximum distance of ca. 0.21 Å with a
RMSD of 0.11 Å. 
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in DMF, before reduction of the nitro group. Thus, reac-
tion of the resulting protected nitroinositol 8 with zinc
powder in the presence of dilute hydrochloric acid as prot-
ic medium afforded 1,2-diaminoinositol 9 in good yield,
preserving the stereochemistry of all stereogenic cen-
tres.16 Finally, the free amino group of the 1,2-diamino-
inositol 9 was protected with a Cbz group under Schotten–
Baumann17 conditions to afford the desired 1,2-diamino-
inositol 10 (Scheme 3).18
Scheme 3  Synthesis of 1,2-diaminoinositol 10
In summary, we describe herein the transformation of a
sugar (D-mannose) into an orthogonally protected 1,2-di-
amino inositol. Our strategy for the construction of the cy-
clohexane ring of target inositol from a sugar aldehyde
involves an intermolecular aza-Henry reaction followed
by an intramolecular Henry reaction. A salient feature of
this sequence is the total stereoselectivity of the ring for-
mation, due to equilibration to the most thermodynamical-
ly stable nitroinositol. This new chemistry could be used
for the transformation of sugar-derived dialdehydes into
2-nitroaminoinositols, that could in turn be converted into
orthogonally protected 1,2-diaminoinositols, a class of
compounds of great synthetic interest that have not been
studied to any great extent. Future efforts will focus on the
application of the new method to the synthesis of diverse
1,2-diaminoinositols with a view to their use for the
preparation of novel organocatalysts.
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